Neuramedy
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $6.6M
Investors
- 5
About Neuramedy
Founded in 2019 and based in Seoul, South Korea, Neuramedy develops pharmaceutical treatments for neurodegenerative diseases.
Who invested in Neuramedy
5 investors across 2 rounds
See all investors in Neuramedy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuramedy
Who invested in Neuramedy?
Neuramedy has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuramedy raised?
Neuramedy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuramedy last raise money?
Neuramedy's most recent round on record is a Series A, in Jul 2020.
What does Neuramedy do?
Founded in 2019 and based in Seoul, South Korea, Neuramedy develops pharmaceutical treatments for neurodegenerative diseases.
Where is Neuramedy headquartered?
Neuramedy is headquartered in Seoul, South Korea.
Which VCs invest in companies like Neuramedy?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Neuramedy's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Neuramedy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.